Pharmafile Logo
Pharmafocus logo
Advanced Search

opioids

Showing 15 posts of 86 posts found.

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023
Research and Development FDA, Opioid overdose, Pharmacy, opioids, orexo

Orexo has announced that its New Drug Application (NDA) for OX124 has been accepted for review by the US Food …

News

FDA approves a second OTC naloxone nasal spray

July 31, 2023
Medical Communications FDA, Nasal Spray, OTC, OTC Products, naloxone, opioids

The US Food and Drug Administration (FDA) has announced that it has approved RiVive, 3mg naloxone hydrochloride nasal spray for …

News

FDA approves prescription nasal spray for opioid overdose treatment

May 23, 2023
Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose

The US Food and Drug Administration (FDA) has announced that it has approved Opvee, the first nalmefene hydrochloride nasal spray …

News
shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

October 14, 2020
Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …

News
800px-temazepam_10mg_tablets-1_1

Canada to roll out automated drug dispensers to help fight opioid crisis

August 27, 2020
Research and Development opioid, opioid crisis, opioids

Canada is set to roll out automated drug dispensers that can provide clean, doctor-prescribed medicine to opioid addicts by scanning …

News
800px-temazepam_10mg_tablets-1

US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation

August 19, 2020
Research and Development opioid crisis, opioid epidemic, opioids

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major …

News
fda

FDA approves opioid Olinvyk for patients with acute pain

August 10, 2020
Sales and Marketing opioid crisis, opioids

The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …

News
fda

FDA launches new pilot program to crack down on unapproved opioids sold online

June 9, 2020
Manufacturing and Production FDA, opiod crisis, opioids

The FDA is collaborating with the National Telecommunications and Information Administration (NTIA) to launch a pilot program to reduce the …

News
fdaoutsideweb

FDA approval for Baudax Bio’s non-opioid painkiller Anjeso

February 24, 2020
Sales and Marketing Anjeso, FDA, opioids, pharma

Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …

News
4829288798_876971e5d4_b

Experts call on NICE to recommended a ban on OTC codeine sales

February 17, 2020
Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs

Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …

News
40542895134_9f6048fa40_b

FDA panel votes against Nektar opioid painkiller

January 15, 2020
Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …

News
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020
Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …

News
14281921538_bacbef11bc_b

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

January 8, 2020
Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …

News
19916066779_1a281ebca0_b

Johnson & Johnson sued by Washington State for role in the opioid crisis

January 3, 2020
Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids

The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024